MusclePharm Executives

MusclePharm employs about 21 people. The company is managed by 4 executives with a total tenure of roughly 49 years, averaging almost 12.0 years of service per executive, having 5.25 employees per reported executive. Discussion of MusclePharm's management performance can provide insight into the enterprise performance.
Ryan Drexler  CEO
Executive CEO
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

MusclePharm Management Team Effectiveness

MusclePharm's management efficiency ratios could be used to measure how well MusclePharm manages its routine affairs as well as how well it operates its assets and liabilities.

MusclePharm Workforce Comparison

MusclePharm is considered to be number one stock in number of employees category among its peers. The total workforce of Consumer Staples industry is now estimated at about 65,873. MusclePharm adds roughly 21.0 in number of employees claiming only tiny portion of stocks in Consumer Staples industry.

MusclePharm Notable Stakeholders

A MusclePharm stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as MusclePharm often face trade-offs trying to please all of them. MusclePharm's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting MusclePharm's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Ryan DrexlerExecutive CEOProfile
John MillsSenior DirectorProfile
Eric ChinChief DirectorProfile
Moore DScChief BoardProfile

About MusclePharm Management Performance

The success or failure of an entity such as MusclePharm often depends on how effective the management is. MusclePharm management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of MusclePharm management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the MusclePharm management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

MusclePharm Workforce Analysis

Traditionally, organizations such as MusclePharm use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare MusclePharm within its industry.

MusclePharm Manpower Efficiency

Return on MusclePharm Manpower

Revenue Per Employee2.4M
Revenue Per Executive12.5M
Net Loss Per Employee612.7K
Net Loss Per Executive3.2M
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in MusclePharm Pink Sheet

If you are still planning to invest in MusclePharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MusclePharm's history and understand the potential risks before investing.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.